Introduction -- Methods -- Clinical prevention guidance -- Special populations -- HIV infection: detection, counseling, and referral -- Diseases characterized by genital, anal, or perianal ulcers -- Management of persons who have a history of penicillin allergy -- Diseases characterized by urethritis and cervicitis -- Chlamydial infections -- Gonococcal infections -- Diseases characterized by vaginal discharge -- Epididymitis -- Human papillomavirus (HPV) infection -- Genital warts -- Cervical cancer screening for women who attend STD clinics or have a history of STDs -- Vaccine-preventable STDs -- Hepatitis C -- Proctitis, proctocolitis, and enteritis -- Ectoparasitic infections -- Sexual assault and STDs -- References -- Terms and abbreviations used in this report.
The oral cephalosporin treatment for gonoccal infections portions of the guideline were updated 2012 by: Update to CDC's sexually transmitted disease treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections (Morbidity and mortality weekly report. 2012 Aug 10;61(31):590-4).
These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18–30, 2009. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 2006;55[No. RR–11]). Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; 5) lymphogranuloma venereum proctocolitis among men who have sex with men; 6) the criteria for spinal fluid examination to evaluate for neurosyphilis; 7) the emergence of azithromycin-resistant Treponema pallidum; 8) the increasing prevalence of antimicrobial-resistant Neisseria gonorrhoeae; 9) the sexual transmission of hepatitis C; 10) diagnostic evaluation after sexual assault; and 11) STD prevention approaches.